Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
Status:
Completed
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oxytocin will decrease craving to use
drugs/alcohol and stress reactivity following exposure to laboratory-induced stress among
Active Duty Service Members with a dual diagnosis of alcohol/substance use disorder (ASUD)
and post-traumatic anxiety.
Phase:
Phase 2
Details
Lead Sponsor:
Jennifer Mitchell University of California, San Francisco
Collaborators:
Congressionally Directed Medical Research Programs Eisenhower Army Medical Center United States Department of Defense United States Naval Medical Center, San Diego